Eloxx Pharmaceuticals Inc. Share Price Today: Live Updates & Key Insights
Eloxx Pharmaceuticals Inc. share price today is $11.75, up -0.5%. The stock opened at $12.29 against the previous close of $12, with an intraday high of $12.35 and low of $11.45.
Eloxx Pharmaceuticals Inc. Share Price Chart
Eloxx Pharmaceuticals Inc.
Eloxx Pharmaceuticals Inc. Share Price Performance
Eloxx Pharmaceuticals Inc. Institutional Holdings
Eloxx Pharmaceuticals Inc. Market Status
Eloxx Pharmaceuticals Inc. Fundamentals
Market Cap 41.24 M
PB Ratio 62.3699
PE Ratio 0.0
Enterprise Value 39.84 M
Total Assets 5.27 M
Volume 93131
Eloxx Pharmaceuticals Inc. Company Financials
About Eloxx Pharmaceuticals Inc. & investment objective
Company Information Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribosome-selective glycoside in a Phase 2 trial for the treatment of rare kidney diseases, including Alport syndrome with nonsense mutations, cystic fibrosis with nonsense mutations, and nephropathic cystinosis with nonsense mutations, as well as in a preclinical stage for the treatment of autosomal dominant polycystic kidney disease with nonsense mutations. It has collaboration with Almirall, S.A. to develop and commercialize ZKN-013, an oral ribosome modulating agent for the treatment of rare skin diseases, such as recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullosa with nonsense mutations. Eloxx Pharmaceuticals, Inc. was incorporated in 1999 and is based in Arlington, Massachusetts.
Organisation Biotechnology
Employees 10
Industry Biotechnology
CEO Mr. Sumit Aggarwal M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Eloxx Pharmaceuticals Inc. FAQs
What is the share price of Eloxx Pharmaceuticals Inc. today?
The current share price of Eloxx Pharmaceuticals Inc. is $11.75.
Can I buy Eloxx Pharmaceuticals Inc. shares in India?
Yes, Indian investors can buy Eloxx Pharmaceuticals Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Eloxx Pharmaceuticals Inc. shares in India?
You can easily invest in Eloxx Pharmaceuticals Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Eloxx Pharmaceuticals Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Eloxx Pharmaceuticals Inc..
Can I buy fractional shares of Eloxx Pharmaceuticals Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Eloxx Pharmaceuticals Inc.?
Eloxx Pharmaceuticals Inc. has a market cap of $41.24 M.
In which sector does Eloxx Pharmaceuticals Inc. belong?
Eloxx Pharmaceuticals Inc. operates in the Biotechnology sector.
What documents are required to invest in Eloxx Pharmaceuticals Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Eloxx Pharmaceuticals Inc.?
The PE ratio of Eloxx Pharmaceuticals Inc. is N/A and the PB ratio is 62.37.